Analysis of clinical features of 36 children with necrotizing pneumonia / 中国小儿急救医学

Objective:To summarize the clinical features, diagnosis, treatment, and outcomes of necrotizing pneumonia(NP)in children, so as to improve the understanding of NP.Methods:Children with NP admitted to the Children′s Medical Center of Hunan Provincial People′s Hospital from December 2012 to June 2020 were selected and divided into respiratory support group(nine cases) and non-respiratory support group(27 cases) according to whether they received respiratory support; and they were also divided into pleural effusion group(28 cases) and non-pleural effusion group(eight cases) according to whether combined with pleural effusion.The clinical data of all children were collected, and the differences between different groups were compared.Results:There were thirty-six children with NP, included 14 boys and 22 girls, with a median age of 30(12, 49) months, and the disease duration was 34(25, 42)days.All children had cough, 34 cases had fever, and the fever peak was 39.5(39.1, 40.0) ℃.Laboratory tests(all peaks) showed that blood white blood cell count was 20.77(15.65, 28.35)×10 9/L, neutrophil count was 15.11(8.52, 20.65)×10 9/L, C-reactive protein(CRP) was 104.00(23.45, 146.50)mg/L, D-dimer was 5.12(1.88, 8.04)mg/L, and lactate dehydrogenase(LDH) was 347.95(284.68, 447.81)U/L.The detection rate of pathogens was 58.33%(21/36), and the most common was Staphylococcus aureus(28.57%, 6/21). Eight cases underwent surgical treatment, including five cases of thoracoscopic surgery and three cases of thoracotomy.All patients improved and were discharged from hospital.The differences in hospital stay, white blood cell count, CRP, procalcitonin and LDH levels between respiratory support group and non-respiratory support group were statistically significant, and the median age, white blood cell count, CRP, D-dimer and LDH between pleural effusion group and non-pleural effusion group were statistically significant(all P<0.05). Further multivariate Logistic regression analysis showed that LDH was a risk factor for NP children receiving respiratory support( P<0.05), the area under the ROC curve of LDH was 0.802, whose the cut-off value was 471.21 U/L.There were no statistically significant differences in the indexes between effusion group and non-pleural effusion group. Conclusion:Children with NP are prone to repeated high fever, high inflammatory markers, and a long course of disease.Staphylococcus aureus is the most common pathogen.Serum LDH≥471.21 U/L is an early independent predictor of respiratory support for NP.

Analysis of clinical features and risk factors of necrotizing pneumonia in children / 北京大学学报(医学版)

OBJECTIVE@#To investigate the clinical characteristics and risk factor analysis of necrotizing pneumonia in children.@*METHODS@#A retrospective study was used to analyze the case data of 218 children with severe pneumonia hospitalized in the Department of Respiratory Medicine, Children's Hospital of Capital Institute of Pediatrics from January 2016 to January 2020, and they were divided into 96 cases in the necrotizing pneumonia group (NP group) and 122 cases in the non-necrotizing pneumonia group (NNP group) according to whether necrosis of the lung occurred. The differences in clinical characteristics (malnutrition, fever duration, hospitalization time, imaging performance, treatment and regression follow-up), laboratory tests [leukocytes, neutrophil ratio, platelet (PLT), C-reactive protein (CRP), procalcitonin (PCT), D-dimer, and lactate dehydrogenase (LDH)] and bronchoscopic performance between the two groups were compared, and Logistic regression analysis of clinical risk factors associated with necrotizing pneumonia was performed to further determine the maximum diagnostic value of each index by subject operating characteristic curve (ROC). The critical value of each index was further determined by the ROC.@*RESULTS@#The differences in age, gender, pathogenic classification, and bronchoscopic presentation between the two groups of children were not statistically significant (P>0.05); whereas the imaging uptake time of the children in the NP group was higher than that in the NNP group (P < 0.05). The differences in malnutrition, fever duration, length of stay, white blood cell count, neutrophil ratio, CRP, PCT, and D-dimer were statistically significant between the two groups (P < 0.05). The imaging uptake time was lower in children under 6 years of age than in those over 6 years of age, and the imaging uptake time for bronchoalveolar lavage within 10 d of disease duration was lower than that for those over 10 d; the imaging uptake time was significantly longer in the mixed infection group than that in the single pathogen infection group. Logistic regression analysis of the two groups revealed that the duration of fever, hospital stay, CRP, PCT, and D-dimer were risk factors for secondary pulmonary necrosis (P < 0.001, P < 0.001, P < 0.001, P=0.013, P=0.001, respectively). The ROC curves for fever duration, CRP, PCT, and D-dimer were plotted and found to have diagnostic value for predicting the occurrence of pulmonary necrosis when fever duration >11.5 d, CRP >48.35 mg/L, and D-dimer > 4.25 mg/L [area under ROC curve (AUC)=0.909, 0.836, and 0.747, all P < 0.001].@*CONCLUSION@#Children with necrotizing pneumonia have a longer heat course and hospital stay, and the imaging uptake time of mixed pathogenic infections is significantly longer than that of single pathogenic infections. Children with necrotizing pneumonia under 6 years of age have more advantageous efficacy of electronic bronchoscopic alveolar lavage within 10 d of disease duration compared with children in the group over 6 years of age and children in the group with disease duration >10 d. Inflammatory indexes CRP, PCT, and D-dimer are significantly higher. The heat course, CRP, PCT, and D-dimer are risk factors for secondary lung necrosis in severe pneumonia. Heat course >11.5 d, CRP >48.35 mg/L, and D-dimer >4.25 mg/L have high predictive value for the diagnosis of necrotizing pneumonia.

Neumonía necrotizante: experiencia en el Hospital Roberto del Río período 2014 a 2020 / Necrotizing pneumonia: experience at the Roberto del Río Hospital from 2014 to 2020

La neumonía necrotizante se refiere a la necrosis del parénquima pulmonar producto de una infección. Existe escasa literatura nacional sobre esta complicación. OBJETIVO: Caracterizar a los pacientes que cursaron con neumonía necrotizante en el Hospital Roberto del Río entre los años 2014 y 2020. MÉTODO: Revisión retrospectiva y descriptiva. RESULTADOS: 22 pacientes. Promedio de edad 4 años 7 meses, 68% masculino, esta complicación correspondió a 1,3% de todos los casos de neumonía hospitalizados en ese periodo. Un 95,5% presentó fiebre y un 59% dificultad respiratoria y tos. La duración promedio de la hospitalización fue de 31 días y del tratamiento antibiótico de 30,3 días. El 63% de los pacientes requirió cirugía. En el laboratorio destaca la leucocitosis y proteína C reactiva elevados con 71,4% > a 90 mg/L (promedio: 211 mg/L) y 52,3% leucocitosis > 15.000 (promedio: 18.127). La ecografía torácica fue la imagen más frecuentemente utilizada (95,5%). Agentes identificados Streptococcus pneumoniae (40%) y Staphylococcus aureus (40%). Un 63,6% ingresó a UCI, 35,7% requirió ventilación mecánica invasiva, 35,7% recibió drogas vasoactivas, 9% requirió de soporte ECMO (Oxigenación por Membrana Extracorpórea) y 1 paciente falleció (4,5%). DISCUSIÓN: en nuestro estudio encontramos una baja incidencia de esta patología, un alto índice de gravedad y una evolución favorable en la gran mayoría de los casos.

Necrotizing pneumonia refers to necrosis of lung parenchyma resulting from an infection. There is little national literature on this complication. OBJECTIVE: To characterize patients with necrotizing pneumonia at the Roberto del Río Children´s Hospital between 2014 to 2020. METHOD: Retrospective and descriptive review. RESULTS: A total of 22 patients, average age 4 years 7 months, male (68%). Average incidence 1.3% in 7 years; 95.5% had fever 59% had respiratory distress and cough. Average duration of hospitalization was 31 days and antibiotic treatment 30.3 days. A 63% of the patients had surgery. Leukocytosis and C-reactive protein (CRP) were elevated, 71.4% CRP > 90 mg /L (average: 211 mg /L) and 52.3% leukocytosis > 15.000 (average: 18.127). Chest ultrasound was used in 95.5%. Main agents identified were Streptococcus pneumoniae (40%) and Staphylococcus aureus (40%). A 63.6% of patients were admitted to ICU, 35.7% required invasive mechanical ventilation, 35.7% received vasoactive drugs, 9% required ECMO (Extracorporeal Membrane Oxygenation), and one patient died (4,5%). DISCUSSION: In our study we found a low incidence of this pathology, a high severity index an a favorable evolution in most cases.

Predictive factors of refractory Mycoplasma pneumoniae pneumonia / 中华实用儿科临床杂志

Mycoplasma pneumoniae is one of the common causes of community-acquired pneumonia in preschool and school-age children.Although it is self-limited in some children, there are still some cases of refractory Mycoplasma pneumoniae pneumonia(RMPP), which are characterized by various intrapulmonary and extrapulmonary complications, such as the formation of bronchial mucus plugs, necrotizing pneumonia and so on, and even endanger the lives of children.In recent years, with the increase of morbidity of RMPP, some studies have shown that early use of corticosteroids can significantly relieve its clinical symptoms and improve prognosis.Therefore, it is essential to understand the pathogenesis of Mycoplasma pneumoniae pneumonia, identify the high risk factors for predicting RMPP and its associated complications, and then formulate relevant prediction scales.

Diagnosis and treatment of necrotizing pneumonia in children / 国际儿科学杂志

Necrotizing pneumonia (NP) is a serious complication of community-acquired pneumonia in children.In recent years, with the deepening understanding of pediatricians, reports on NP have increased year by year.The early lesion of NP is characterized by the consolidation of lung tissue.With the progression of the disease, the involved lung tissue appears liquefaction and necrosis, and eventually multiple cysts or cavities are formed.Clinical diagnosis is mainly based on imaging.Previous studies have shown that NP is mostly found in streptococcus pneumoniae and staphylococcus aureus infections.In recent years, mycoplasma pneumoniae has been found to be the main pathogen of necrotizing pneumonia, and adenovirus and influenza virus infections have also been frequently reported.On the basis of reasonable anti-infection treatment, most of the children have a good prognosis by treatement of glucocorticoid, gamma globulin, bronchoscope lavage, closed thoracic drainage, etc.

Neumonía necrotizante en niños: 10 años de experiencia en un hospital pediátrico de referencia / Necrotizing pneumonia in children: 10 years of experience in a Pediatric Reference Hospital / Pneumonia necrosante em crianças: 10 anos de experiência em um Hospital Pediátrico de Referência

Resumen: Introducción: neumonía necrotizante (NN) es una complicación frecuente en niños hospitalizados por neumonía adquirida en la comunidad (NAC), caracterizada por importante morbilidad. En 2009, se elaboró una definición de caso, que permitió unificar criterios y racionalizar recursos en la asistencia de estos niños. Objetivo: describir características clínicas y evolutivas de niños que desarrollaron NN en los últimos 10 años. Metodología: estudio descriptivo de niños hospitalizados por NN entre 1/1/2009 y 31/12/2018. Definición de caso: neumatoceles y uno o más de los siguientes criterios: mal estado general, fiebre persistente o recurrente, leucocitosis mayor a 30.000 o menor a 5.000/mm3, proteína C reactiva mayor a 120 mg/dl, láctico deshidrogenasa en líquido pleural mayor a 2.500 UI/L y/o fístula broncopleural (FBP). Se describieron características epidemiológicas, clínicas, etiológicas y evolutivas. Resultados: se diagnosticó NN en 197 niños (7,92% de las hospitalizaciones por NAC), con número anual de casos y tasas/10.000 egresos variables. La mediana de edad fue de 25 meses; 89,8% eran sanos. La fiebre previa al diagnóstico tuvo mediana de cinco días. Tenían neumonía multilobar 58%, insuficiencia respiratoria 62%, sepsis 19%, empiema 80% y fístula bronquio-pleural 51%. Persistieron con fiebre mediana por siete días. Requirieron cuidados intensivos 46% y asistencia ventilatoria mecánica 18%. Los reactantes de fase aguda al ingreso fueron elevados. Se identificó agente etiológico en 102 casos, S. pneumoniae en 92. Fallecieron dos niños. Conclusiones: NN fue una complicación frecuente en niños hospitalizados por NAC. La presentación clínica y la evolución fueron graves. La identificación etiológica fue elevada, la mayoría correspondió a S. pneumoniae. La mortalidad fue baja.

Summary: Introduction: necrotizing pneumonia (NP) is a complication of community-acquired pneumonia (CAP) in hospitalized children, with significantly high morbidity. A case definition was devised in 2009, which enabled physicians to unify criteria and rationalize resources for the assistance of children with NP. Objective: describe clinical characteristics and evolution of children who developed NP. Methodology: descriptive study, NP hospitalized children between 1/1/2009 and 12/31/2018. Case definition: pneumatoceles and one or more of the following criteria: malaise, persistent/recurrent fever, white blood cell count over 30,000 or less than 5.000/mm3, C-reactive protein over 120 mg/dL, lactic dehydrogenase in pleural fluid over 2,500UI/L and/or bronchopleural fistula (BPF). Clinical, epidemiological, etiological and evolutionary characteristics were described. Results: NP was diagnosed in 197 children (7.92% of CAP hospitalizations), with variable annual cases and annual rate/10,000 discharges. Children had a median age of 25 months; 89.8% were previously healthy. They presented fever prior to diagnosis, median 5 days, multilobar pneumonia 58%, respiratory failure 62%, sepsis 19%, empyema 80% and BPF 51%, persistent fever median 7 days. 46% required intensive care and 18% required assisted mechanical ventilation. Acute phase reactants on admission were high. An etiological agent was identified in 102 cases, S.pneumoniae in 92. Two children died. Conclusions: NP was a frequent complication in CAP hospitalized children. Clinical presentation and evolution were severe. The etiological identification was high, most of them corresponded to S. pnuemoniae. Mortality was low.

Resumo: Introdução: a pneumonia necrosante (PN) é uma complicação da pneumonia adquirida na comunidade (PAC) em crianças hospitalizadas, com morbidade significativamente elevada. Em 2009, elaborou-se uma definição de caso, que possibilitou aos médicos unificar critérios e racionalizar recursos para o atendimento à criança com PN. Objetivo: descrever as características clínicas e evolutivas de crianças que desenvolveram PN nos últimos 10 anos. Metodologia: estudo descritivo de crianças internadas por PN entre 01/01/2009 e 31/12/2018. Definição de caso: pneumatoceles e um ou mais dos seguintes critérios: mau estado geral, febre persistente ou recorrente, leucocitose superior a 30.000 ou inferior a 5.000 / mm3, proteína C reativa superior a 120 mg / dl, desidrogenase láctica no líquido pleural superior 2.500 UI / L e / ou fístula broncopleural (BPF). Descreveram-se características epidemiológicas, clínicas, etiológicas e evolutivas. Resultados: a PN foi diagnosticada em 197 crianças (7,92% das internações por PAC), com número de casos e taxas anuais variáveis/10.000 altas. A idade média foi de 25 meses; 89,8% eram saudáveis. A febre antes do diagnóstico teve uma mediana de 5 dias. Eles tinham 58% de pneumonia multilobar, 62% de insuficiência respiratória, 19% de sepse, 80% de empiema e 51% de FBP. Eles persistiram com febre mediana por 7 dias. 46% necessitaram de cuidados intensivos e 18% de assistência ventilatória mecânica. Os reagentes de fase aguda na admissão foram elevados. Em 102 casos foi identificado um agente etiológico, S. pneumoniae em 92. 2 crianças morreram. Conclusões: NP é uma complicação frequente em crianças hospitalizadas por PAC. O quadro clínico e a evolução foram graves. A identificação etiológica foi alta, a maioria correspondeu a S. pneumoniae. A mortalidade foi baixa.

Neumonía necrosante causada por el serotipo 3 del Streptococcus pneumoniae a pesar de la inmunización con la VCN13 / Necrotizing pneumonia caused by Streptococcus pneumoniae serotype 3 despite PCV13

El Streptococcus pneumoniae es la causa más frecuente de una neumonía complicada. La neumonía neumocócica necrosante (NNN) constituye una complicación rara y relacionada con el serotipo. Los serotipos 1, 3, 14, 15, 19A y 33 fueron los más frecuentemente informados en los niños con NNN antes de la inmunización. A pesar de la práctica extendida de la vacunación, el S. pneumoniae sigue siendo la causa de las enfermedades invasivas. Aquí se informa el caso de un niño que había recibido el esquema completo con la vacuna neumocócica conjugada de 13 serotipos (VCN13) diagnosticado con NNN del serotipo 3. La progresión de la enfermedad invasiva por S. pneumoniae debe considerarse a pesar de la inmunización completa.

Streptococcus pneumoniae is the most common cause of complicated pneumonia. Pneumococcal necrotizing pneumonia (PNP) is a rare and serotype related complication. Serotypes 1, 3, 14, 15, 19A and 33 were the most reported serotypes in children with PNP before immunization. Despite widespread vaccination, S. pneumoniae is still cause of invasive diseases. We reported a child, fully immunized with 13-valent conjugated pneumococcal vaccine (PCV13) who was diagnosed PNP due to serotype 3. Breakthrough invasive infection caused by S. pneumoniae must be considered in mind despite fully vaccination.

Neumonía necrotizante en paciente pediátrico / Necrotizing pneumonia in a pediatric patient

La neumonía es la causa de muerte de aproximadamente 4 millones de niños al año en todo el mundo, la gran mayoría en países en desarrollo. En el primer año de vida, la incidencia es de 15-20 casos/1.000 niños/año. De 1 a 5 años asciende a 30-40 casos y, de nuevo, desciende en los mayores de 5 años a 10-20 casos/1.000 niños/año. Es una infección aguda del tracto respiratorio inferior adquirida en la comunidad con una duración inferior o igual a 14 días, que produce tos y/o dificultad respiratoria y con evidencia radiológica de infiltrado pulmonar agudo. El Streptococcus pneumoniae es el principal agente bacteriano. Se presenta el caso de un preescolar masculino de 2 años de edad. Inicia su enfermedad actual con rinorrea hialina anterior, hipertermia no cuantificada, tos seca. Es evaluado por facultativo y realizan paraclínicos que reportan leucocitosis, neutrofília y trombocitosis reactiva, diagnostican infección respiratoria baja e indican tratamiento antimicrobiano vía oral, el cual cumple sin evidenciar mejoría. Posteriormente se asocia dificultad respiratoria, consulta a centro de salud donde ingresan e indican tratamiento médico durante 48 horas sin mejoría clínica, refieren al Hospital Universitario de Caracas en regulares condiciones generales. En TAC de tórax se evidencian imágenes sugestivas de neumonía necrotizante bilateral, se indica doble antibioticoterapia durante 11 días para dar cobertura a Streptococcus pneumoniae resistente y/o Staphylococcus Aureus meticilino resistente adquirido en la comunidad, productor de leucocidina Panton - Valentine. Con evolución clínica satisfactoria egresa, con antibioticoterapia vía oral por 21 días y control por Neumopediatría(AU)

Pneumonia is the cause of death of approximately 4 million children a year around the world, the vast majority in developing countries. In the first year of life, the incidence is 15-20 cases/1,000 children/year. From 1 to 5 years it reaches 30-40 cases and, again, it goes down in those older than 5 years to 10-20 cases/1,000 children/year. It is an acute infection of the lower respiratory tract acquired in the community with a duration of less than or equal to 14 days, which causes cough and / or respiratory distress and with radiological evidence of acute pulmonary infiltrate. Streptococcus pneumoniae is the main bacterial agent. The case of a 2-year-old male preschooler is presented. He begins his current illness with anterior hyaline rhinorrhea, hyperthermia not quantified, dry cough. It is evaluated by a physician and performs paraclinics that report leukocytosis, neutrophilia and reactive thrombocytosis, diagnose a lower respiratory infection and indicate antimicrobial treatment by oral route, which does not show improvement. Afterwards, respiratory distress is associated, consultation with the health center where they enter and indicate medical treatment during 48 hours without clinical improvement, refer to the University Hospital of Caracas in regular general conditions. Chest CT shows suggestive images of bilateral necrotizing pneumonia, double antibiotic therapy is indicated for 11 days to cover resistant Streptococcus pneumoniae and / or community-acquired methicillin-resistant Staphylococcus Aureus, producer of Panton - Valentine leukocidin. With satisfactory clinical evolution, he withdrew, with oral antibiotic therapy for 21 days and control by Pneumopediatrics(AU)

Diagnosis and treatment of necrotizing pneumonia in 32 children with flexible bronchoscopy / 中国实用儿科杂志

OBJECTIVE: To evaluate the diagnostic and therapeutic value of flexible bronchoscopy in children with necro⁃tizing pneumonia. METHODS: Clinical data of children diagnosed with necrotizing pneumonia in the Department of Pedi⁃atrics of the First Hospital of Jilin University from December 2016 to December 2017 were collected. The general clini⁃cal manifestations,laboratory examination results,chest X-ray or lung CT,flexible bronchoscope and other examinations of all the children were analyzed retrospectively. Based on the characteristics,diagnosis,treatment and prognosis,the ad⁃vantages of flexible bronchoscopy in this disease were analyzed. RESULTS: All the 32 cases were diagnosed as necrotizing pneumonia by imaging examination,with an average diagnosis time of 14.1 d. All 32 cases of children with necrotizing pneumonia received flexible bronchoscopy and alveolar lavage. The alveolar lavage in 32 cases presented turbidity mito⁃ta-like changes,which had high sensitivity in the diagnosis of necrotizing pneumonia. The average time for mitota-like changes in alveolar lavage was 6.7 days. CONCLUSION: Flexible bronchoscopy is an important method in the diagnosis and treatment of necrotizing pneumonia,and the change of alveolar lavage fluid is a sensitive index for early prediction of necrotizing pneumonia.

Comparative analysis of clinical characteristics and prognosis between bacterial necrotizing pneumonia and Mycoplasma pneumoniae necrotizing pneumonia in children / 中华儿科杂志

Objective@#To compare the characteristics of Mycoplasma pneumoniae necrotizing pneumonia (MPNP) and bacterial necrotizing pneumonia (BNP), and explore the biomarkers for differentiation of MPNP from BNP.@*Methods@#A retrospective, observational study of 52 necrotizing pneumonia (NP) cases who were hospitalized in our hospital from January 2008 to December 2017 was conducted. According to the pathogen causing NP, patients were divided into two groups, BNP and MPNP, and the clinical manifestations, laboratory data, imaging findings, hospital course and prognosis between these groups were analyzed.@*Results@#This study enrolled 19 boys and 33 girls, and the median ages of patients were 4.4 (0.1-13.8) years old. Of the totally of 52 NP patients, 19 were in the BNP group (9 boys and 10 girls), 33 were in the MPNP group (10 boys and 23 girls). The mean age of MPNP patients was much older than that of BNP patients (5.2 (2.3-13.2) years vs. 1.8 (0.1-13.8) years, Z=-0.128, P<0.01). The number of patients with tachypnea and pleural effusion septation were significantly higher in BNP patients than those in MPNP patients (15 cases vs. 4 cases, χ2=23.222, P<0.01; 14 cases vs. 1 case, χ2=29.326, P<0.01), which more needed to oxygentherapy (18 cases vs. 12 cases, χ2=16.833, P<0.01) and undergo chest drainage (9 cases vs. 4 cases, χ2=5.829, P=0.022); while the number of patients required bronchoalveolar lavage was higher in MPNP patients than that in BNP patients (5 cases vs. 32 cases, χ2=29.326, P<0.01). The values of white blood cell (WBC) (23.2 (5.2-67.1)×109/L vs. 9.7 (6.3-18.7)×109/L, Z=-4.855, P<0.01), procalcitonin (PCT) (3.69 (0.23-90.15) mg/L vs. 0.28 (0.02-1.44) mg/L, Z=-3.207, P=0.001), C reactive protein (CRP) (160 (94-220) mg/L vs. 90 (5-134) mg/L, Z=-4.337, P<0.01), interleukin (IL)-10 (11.7 (4.2-401.5) ng/L vs. 4.8 (2.0-23.4) ng/L, Z=-2.278, P=0.023), pleural fluid cell count (5 200 (120-50 000)×106/L vs. 790 (68-6 920)×106/L, Z=-3.125, P=0.002), pleural fluid lactic dehydrogenase (LDH) (3 990 (589-29 382) U/L vs. 2 211 (673-3 993) U/L, Z=-2.488, P=0.013) in BNP group were significantly higher than those in MPNP group; while the values of pleural fluid glucose(0.43 (0.03-18.00) mmol/L vs. 5.95 (4.27-7.87) mmol/L, Z=-2.795, P=0.005), serum tumor necrosis factor (TNF)-α (2.3 (1.0-2.8) ng/L vs. 2.6 (1.3-109.2) ng/L, Z=-2.113, P=0.035) and interferon (IFN)-γ (4.8 (2.6-7.7) ng/L vs. 11.9 (2.9-154.6) ng/L, Z=-2.455, P=0.014) were lower in BNP group than those in MPNP group. Meanwhile, the mean time from the onset of symptoms to the discovery of necrotic lesions was longer in MPNP group than that in BNP group ((20.6±6.4) days vs. (14.6±6.2) days, t=3.029, P=0.004). After treatments, all patients were discharged without death, WBC and PCT recovered more quickly in MPNP group than those in BNP group (12 (0-24) days vs. 0 (0-23) days, Z=-4.484, P<0.01; 10 (5-15) days vs. 0 (0-23) days, Z=-3.244, P=0.001). As to prognosis, 34 cases were followed up, and the results showed that patients recovered without surgical intervention, and chest lesions were resolved within 3.0 (1.0-8.0) months, and the time to necrosis disappearance was similar in the BNP group and MPNP greup (3.0 (1.0-8.0) months vs. 3.0 (1.0-8.0) months, Z=-0.128, P=0.001). In receiver operator characteristic curve analysis, the cut-off values for the age, WBC, CRP, PCT, pleural fluid cell count and pleural fluid glucose were set at 2.4 years of age, 17.2×109/L, 157 mg/L, 1.505 mg/L, 2 630×106/L and 3.73 mmol/L, respectively.@*Conclusions@#NP is found to be severe and prolonged, yet, reversible through proper therapy, such as rational antibiotics application. The age, WBC, CRP, PCT, pleural fluid cell count and pleural fluid glucose could be used as biomarkers to differentiate MPNP from BNP in children.

Mycoplasma Pneumoniae-Associated Necrotizing Pneumonia in Children: a case-report / 고신대학교의과대학학술지

Mycoplasma pneumoniae is the most common bacterial strain causing atypical pneumonia in children and adolencents. Although it is known to cause mild symptoms, it can also cause severe pulmonary or extrapulmonary complications in rare cases. Necrotizing pneumonia (NP) is often reported as a complication of Streptococcus pneumoniae and is very rarely caused by M. pneumoniae. We report a case in which a 5-year-old boy was diagnosed with lobar pneumonia with symptoms that aggravated even with macrolide antibiotic treatment. Anti-mycoplasma pneumoniae Ig-M test yielded high values, and direct polymerase chain reaction results were also positive. NP caused by M. pneumoniae was confirmed on computed tomography. After treatment involving tosufloxacin and systemic steroid, the lesion decreased in size and improved gradually when followed-up for more than 1 year. The patient did not have any predisposing or risk factors for NP.

Imaging characteristics and serum CGreactive protein,plasma DGdimer change of necrotizing pneumonia caused by mycoplasma pneumoniae infection in children / 实用放射学杂志

Objective To investigate the imaging features of necrotizing pneumonia(NP)caused by mycoplasma pneumoniae in children and to review the changes of serum CGreactive protein (CRP)and plasma DGdimer,which may provide an objective and effective help for clinicians.Methods 54 children with mycoplasma pneumoniae pneumonia (MPP)infection in our hospital were studied retrospectively,including 24 cases of NP and 30 cases of nonGNP (the control group).The dynamic changes of chest imaging,serum CRP and plasma DGdimer were compared between two groups.Results Chest imaging in NP group:All cases showed consolidation and necrosis,accompanied by pulmonary cavities,pleural effusion,bronchiectasia,and thickening of the bronchial wall.Decreased enhancement areas could be found in all 24 cases by enhanced CT.The review after treatment showed that the pulmonary consolidation was absorbted or narrowed,accompanied by cavities in lung,atelectasis,and pleura thickening.The imaging of non NP group showed mainly patches and spots shadow in lung, and only a little consolidation.After treatment,the lung lesions were basically absorbed.Only a few cases had fibrotic streaks and pleural thickening.The peak values of serum CRP in group NP and non NP group were respectively 91(33－266)mg/L,37(18－189) mg/L,and the duration of the abnormity were 1 9(1 1－3 8)d and 8(4－1 9)d.The peak values of plasma DGdimer in the 2 groups were respectively 2 3 78(1 9 84－5 908)ng/mL,1 7 6(1 2－41 9)ng/mL,and the duration of the abnormity were 24(13－64)d and 3(0－10)d. There were significant differences between the 2 groups with all parameters above.Conclusion The imaging characteristics of NP caused by MP in children include consolidation,necrosis (decreased enhancement areas in consolidation),pneumothorax ,cavities ,cystic degenerations, atelectasis,bronchial wall thickening,pleural effusion and pleura thickening.The course of NP was long,and the absorption was slow. The peaks value of serum CRP and plasma DGdimer in NP group were significantly higher than those in the non NP group,and the duration was longer than that in non NP group.Therefore,the clinicians should pay more attention to CR,DGdimer and chest imaging,which may help clinicians with the diagnosis and treatment.

Clinical characteristics of necrotizing pneumonia caused by Mycoplasma pneumoniae infection in children / 临床儿科杂志

Objectives To analyze the clinical characteristics, treatment and prognosis of necrotizing pneumonia caused by Mycoplasma pneumoniae (MP) infection in children. Method The clinical data of children with necrotizing pneumonia cause by MP infection from October 2016 to October 2017 were retrospectively analyzed. Results A total of 26 children (10 males and 16 females) with an average age of (5.76±2.60) years, were enrolled in the study. All children were characterized by fever and cough. High fever ( ≥ 39.0 ℃) was seen in 23 cases (88.5％) and the total duration of fever was (16.88±7.42) days. Pulmonary auscultation showed a reduction in respiratory sounds in all children. The range of peripheral blood leukocytes were (9.0～36.8) ×109/L, mean peak neutrophil ratio was (69.2±13.2) ％, and the range of C-reactive protein (CRP) was (1～202.5) mg/L. The mean value of lactic dehydrogenase (LDH) was (448±247) U/L. At the beginning of the disease, the chest images showed homogeneous solid high-density images over the whole lung lobe and 20 cases (76.9％) were complicated with pleural effusion. At the later stage, lung CT showed thin-walled cavities or multiple air-containing cysts on the basis of lung consolidation. Fiberoptic bronchoscopy showed lumen obstruction caused by mucus plugs in 23 cases (88.5％) . All the children were treated with methylprednisolone. The dose of 2 mg/ (kg·d) was effective in 21 cases and the fever was relieved in 5 cases after the dose was adjusted to 4 mg/ (kg·d) , and the average hormone application time was (13.08 ± 8.38) d. The median length of hospital stay was [16.5 (7～32) ] d. Two cases were lost to follow-up and 24 cases finished 6-month follow-up. Lung CT showed almost complete recovery of the lungs in 16 cases, residual pleural hypertrophy in 5 cases, and bronchiectasis in 1 case and bronchiolitis obliterans in 2 cases. Conclusion Necrotic pneumonia in children caused by MP infection is characterized by persistent high fever, decreased respiratory sounds, lung consolidation and mucus plugs induced lumen obstruction. The prognosis is relatively good after active anti-infection and hormone therapy.

Staphylococcus aureus resistente a meticilina / Methicillin-resistant Staphylococcus aureus

La incidencia de infecciones causadas por cocos grampositivos ha aumentado considerablemente desde la década del 80 y particularmente durante la del 90. La emergencia y diseminación de microorganismos multirresistentes ocurre tanto en hospitales como en la comunidad, resultado de la interacción de muchos factores ante la presión selectiva para sobrevivir en presencia de los antibióticos usados. El objetivo es describir las características epidemiológicas, clínicas y de laboratorio de los pacientes con infección por Staphylococcus aureus meticillin resistente. Se realizó un estudio descriptivo de serie de casos. Se incluyeron los niños que tenían infección clínica y microbiológicamente documentadas por Staphylococcus aureus meticillin resistente. De 42 pacientes ingresados con infección por S. aureus, en la terapia pediátrica infantil del Hospital Comandante Pinares, en el período comprendido de julio 2012 a octubre del 2015, se seleccionaron 5 pacientes en quienes se aísla por hemocultivo y cultivo de secreciones el Staphylococcus aureus meticillin resistente, corroborado en el Instituto de Medicina Tropical "Pedro Kouri". Los resultados se describen por variables y en distribución de frecuencias. Se instauró tratamiento al 100 % de los pacientes con vancomicina y evolucionaron satisfactoriamente el 80 % de estos. Se presentaron complicaciones relacionadas con el órgano inicialmente afectado y también a distancia. Se cumplieron protocolos de tratamiento para la sepsis severa, el shock séptico y la disfunción múltiple de órganos. Se logró una supervivencia del 80 %. Se concluye que la infección por Staphylococcus aureus meticillin resistente constituye una enfermedad emergente en nuestro medio. La realización de un adecuado estudio de cada caso, determina un mejor manejo terapéutico de esta infección.

The incidence of infections caused by gram-positive cocci has increased considerably since the 1980s and particularly during the 1990s. Emergence and dissemination of multiresistant microorganisms occur in hospitals as well as in the community, as a result of the interaction of many factors in response to the selective pressure to survive in the presence of the antibiotics used. The objective of the study was to describe the epidemiological, clinical and laboratory characteristics of patients infected by methicillin-resistant Staphylococcus aureus. A descriptive study was conducted of a case series. The sample was composed of children with clinically and microbiologically documented infection by methicillin-resistant Staphylococcus aureus. Of 42 patients hospitalized with infection by S. aureus in the pediatric therapy service of Comandante Pinares Hospital from July 2012 to October 2015, five were selected from whom methicillin-resistant Staphylococcus aureus was isolated by blood and secretion culture and confirmed at Pedro Kourí Tropical Medicine Institute. The results are shown per variable and in frequency distributions. All the patients were treated with vancomycin and 80% had a satisfactory evolution. Complications were related to the organ initially affected as well as to distant organs. Treatment protocols for severe sepsis, septic shock and multiple organ dysfunction were complied with. 80% survival was achieved. It is concluded that infection by methicillin-resistant Staphylococcus aureus is an emerging disease in our environment. An appropriate study of each case leads to better therapeutic management of this infection.

Group B streptococcal necrotizing pneumonia in a diabetic adult patient / Neumonía necrosante por estreptococo del grupo B en un paciente adulto diabético

The aim of this report is to describe a rare case of necrotizing pneumonia due to group B Streptococcus serotype III in a relatively young male adult (48 years old) suffering from diabetes. The organism was isolated from his pleural fluid and was only resistant to tetracycline. The patient first received ceftazidime (2 g/8 h i.v.) + clindamycin (300 mg/8 h) for 18 days and then he was discharged home and orally treated with amoxicillin clavulanic acid (1 g/12 h) for 23 days with an uneventful evolution. As in the cases of invasive infection by Streptococcus pyogenes, clindamycin could prevent streptococcal toxic shock syndrome.

El objetivo de esta presentación es describir un caso raro de neumonía necrosante debida a estreptococo del grupo B serotipo III en un diabético adulto de sexo masculino relativamente joven (48 años). El microorganismo fue aislado de líquido pleural y resultó ser resistente solo a tetraciclina. El paciente recibió ceftacidima (2 g/8 h iv) + clindamicina (300 mg/8 h) durante 18 días y luego fue dado de alta, bajo tratamiento oral con amoxicilina-ácido clavulánico (1 g/12 h). Este tratamiento se mantuvo durante 23 días, con buena evolución. Como en casos de infecciones invasivas por Streptococcus pyogenes, es posible que la clindamicina haya evitado la aparición del síndrome de shock tóxico estreptocócico.

Clinical analysis of 49 cases of necrotizing pneumonia in children / 中华实用儿科临床杂志

Objective To explore the clinical characteristics,pathogens,inflammatory biomarkers,therapeutic methods and prognosis of necrotizing pneumonia (NP) in children.Methods The clinical data of children with NP who were admitted to the Department of Pediatrics of Shengjing Hospital of China Medical University from October 2010 to October 2015 were collected.The data included demographic data,laboratory test results,intrapulmonary complications,therapeutic methods and so on were analyzed,retrospectively.Results Forty-nine pediatric patients with NP were enrolled,31 cases were boys,18 cases were girls;the average age of the patients were 2.5 years (4 months-13 years).The average febrile time were (15.08 ± 5.92) d,and the hospital stay was (21.19 ± 10.83) d,respectively.The median value of peripheral blood leukocyte count was 17.7 × 109/L,the average of neutrophils ratio was (67.62 ± 18.52)％,and the median value of C-reactive protein (CRP) and procalcitonin (PCT) was 97.9 mg/L and 0.54 μg/L,respectively.Nineteen cases had Mycoplasma pneumoniae (MP) infection,16 cases with pneumonia chlamydia infection,9 cases complicated with MP and chlamydia pneumoniae infection,and 8 cases with positive bacterial culture,and 10 cases suffered from the intrapulmonary complications.Forty-seven cases got better prognosis with the treatment of antibiotics,glucocorticoids,intravenous immunoglobulin and other comprehensive therapeutic methods such as bronchoalveolar lavage with fiber bronchoscope and closed thoracic drainage.Conclusions NP is a severe complication of community-acquired pneumonia in children,and the occurrence of NP should be alerted in the children who have persistent high fever,higher inflammatory index and pleural effusion,but the great majority of patients do recover fully after comprehensive treatment.

Neonatal necrotizing pneumonia:two case report and literature review / 临床儿科杂志

Objective To explore the clinical features, diagnosis, and treatment of neonatal necrotizing pneumonia. Methods The clinical data of two cases of neonatal necrotizing pneumonia were retrospectively analyzed. The clinical features, diagnosis, and treatment of neonatal necrotizing pneumonia in literatures were summarized. Results Two cases were diagnosed of community-acquired Staphylococcus aureus necrotizing pneumonia and had the onset with fever. The chest X-ray showed exudative change with cystic shadow. The chest CT showed multiple cavity changes. The sputum and blood cultures were positive for Staphylococcus aureus. Both of them were effectively treated by vancomycin. The imaging was improved during the follow-up. Searching the database, 4 related literatures were being found, and there were totally 7 cases of neonatal necrotizing pneumonia including current 2 cases. The main features were as follows: The pathogenic bacteria in all cases include Staphylococcus aureus. One case was combined with pseudomonas aeruginosa. Six cases were community-acquired infections. All of them were non-immune deficiency newborn. Six cases were primary necrotizing pneumonia. Six cases were unilateral lung involvement. Five cases got fever, 5 cases had septicemia, 3 cases had pleural effusion, 2 cases had aerothorax, one case had bronchial chest and 2 cases had extrapulmonary infection. The C-reactive protein was increased in all cases. Three cases need mechanical ventilation. Six cases had a good prognosis. Conclusions The main pathogenic bacterium in neonatal necrotizing pneumonia was Staphylococcus aureus. The diagnosis was mainly depends on the typical imaging and pathogenic examination. The treatment is mainly the use of antibiotic for gram positive cocci.

Neumonías necrosantes graves con empiema asociado / Severe necrotizing pneumonias with secondary empyemas

Introducción: Las neumonías necrosantes (NN) con empiema son una enfermedad grave y un desafío multidisciplinario. El objetivo de este estudio es realizar una caracterización epidemiológica y, en forma secundaria, analizar su tratamiento y evolución. Presentación de casos: Se realizó un estudio retrospectivo de una serie de casos consecutivos con NN con empiema que se presentaron en el Hospital Padre Hurtado. Siete (77,8%) eran de sexo masculino. La mediana de edad fue de 53 (rango 21-73) años. El 44% presentaban comorbilidades (diabetes, HTA o enfermedades neurológicas). El 44% presentaban abuso de drogas y 3 estaban en un estado de desnutrición severa. Manejo y evolución: La mediana de tiempo de hospitalización fue de 41 (rango 16-129) días. En 4 pacientes el germen aislado fue un Enterococcus faecalis. Complicaciones torácicas ocurrieron en el 33,3% de los pacientes. Un paciente requirió una lobectomía, un paciente una fenestración y otro paciente falleció. Discusión: Las NN con empiemas son raras. Sin embargo, frente a la asociación de diabetes, desnutrición y abuso de drogas continuaremos viendo estos casos de difícil manejo con elevada morbimortalidad.

Introduction: Necrotizing pneumonia complicated with empyema is a life-threatening condition that challenges multidisciplinary teams. The aim of this study is to perform an epidemiological characterization of these patients, and secondly, analyse their treatment and outcomes. Case presentation: A retrospective analysis of a series of consecutive patients experiencing necrotizing pneumonia with empyema who presented at Hospital Padre Hurtado. Seven (77.8%) were male. The median age was 53 (range 21-73) years. 44% presented with comorbidities (diabetes, high blood pressure, and neurological diseases). 44% presented drug abuse consumption and three (33.3%) were in a state of severe malnutrition. Management and outcome: The median time of hospitalization was 41 (range 16-129) days. Thoracotomies were performed in eight (83.2%) of the patients. In four patients, the isolated bacteria's were Enterococcus faecalis. Thoracic complications occurred in three (33.3%) patients. One patient required a lobectomy, one patient a fenestration and one (11.1%) patient died. Discussion: Necrotizing pneumonias complicated with empyema are rare, however, if there is an association with drug abuse, diabetes and malnutrition, we will continue to see such challenging cases with high morbidity and mortality.

Infección diseminada por Staphylococcus aureus positivo para leucocidina de Panton-Valentine en un niño / Disseminated Panton-Valentine Leukocidin-Positive Staphylococcus aureus infection in a child

La leucocidina de Panton-Valentine (LPV) es una exotoxina producida por muchas cepas de Staphylococcus aureus, y un importante factor de virulencia. Una infección por S. aureus positivo para LPV deriva en infecciones rápidas y graves de partes blandas y neumonía necrosante en adolescentes sanos, y la tasa de mortalidad es elevada. Presentamos el caso de un paciente de 12 años hospitalizado por fiebre, dificultad respiratoria y coxalgia en el que se identificó neumonía necrosante con embolia pulmonar séptica, absceso del psoas, celulitis y osteomielitis. En el hemocultivo del paciente se aisló S. aureus sensible a la meticilina (SASM) positivo para LPV.

Panton-Valentine leukocidin (PVL) is an exotoxin that is produced by many strains of Staphylococcus aureus, and an important virulence factor. A PVL-positive S. aureus infection leads to rapid and severe infections of soft tissue and necrotizing pneumonia in healthy adolescents, and has a high mortality. This case report included a 12-year-old male patient who admitted for fever, respiratory distress and hip pain and was identified with necrotizing pneumonia with septic pulmonary embolism, psoas abscess, cellulitis and osteomyelitis. The PVL positive methicillin-sensitive S. aureus (MSSA) was isolated in the patient blood culture.

Neumonía necrosante adquirida en la comunidad causada por Staphylococcus aureus resistente a meticilina ST30-SCCmecIVc-Spat019-PVL positivo en San Antonio de Areco, Argentina / Community-acquired necrotizing pneumonia caused by methicillin-resistant Staphylococcus aureus ST30-SCCmecIVc-spat019-PVL positive in San Antonio de Areco, Argentina

Community-acquired methicillin-resistant Staphylococcus aureus is the first cause of skin and soft tissue infections, but can also produce severe diseases such as bacteremia, osteomyelitis and necrotizing pneumonia. Some S. aureus lineages have been described in cases of necrotizing pneumonia worldwide, usually in young, previously healthy patients. In this work, we describe a fatal case of necrotizing pneumonia due to community-acquired methicillin-resistant S. aureus clone ST30-SCCmecIVc-spat019-PVL positive in an immunocompetent adult patient.

Staphylococcus aureus resistente a meticilina adquirido en la comunidad es la primera causa de infecciones de piel y partes blandas, aunque también puede producir infecciones graves, como bacteriemia, osteomielitis y neumonía necrotizante. Algunos linajes de S. aureus se han asociado a casos de neumonía necrotizante en el mundo, generalmente en pacientes jóvenes previamente sanos. En este trabajo comunicamos un caso fatal de neumonía necrotizante causado por el clon de S. aureus resistente a meticilina adquirido en la comunidad ST30-SCCmecIVc-spat019-LPV positivo, en un paciente adulto inmunocompetente